US health agency questions robustness of AstraZeneca's COVID-19 vaccine trial data
AstraZeneca Plc may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large scale US trial, a US health agency said Tuesday in a fresh setback for the shot.
from bdnews24.com - Home https://ift.tt/3f7H5Bp
from bdnews24.com - Home https://ift.tt/3f7H5Bp
No comments